Venlon Enterprises Limited
Venlon Enterprises Limited is a Public Non-govt company company incorporated in 1983 and based in Karnataka, India. Venlon Enterprises Limited operates in Chemical substances used in the manufacture of anti-biotic, manufacturing (NIC 24231) with authorized capital of ₹26.50 Cr and paid-up capital of ₹26.12 Cr. For 2025-26, the company reported revenue of ₹7.94 Cr and a net loss of ₹3.38 Cr. The board has 3 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
VENLON ENTERPRISES LIMITED is the legal entity of Venlon Enterprises.
Quick facts
Directors
3 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +32d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +22d | filed |
| MGT-7 | FY2022-23 | 22 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Venlon Enterprises Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 250101518 | Axis Bank Ltd(Bank) | ₹19.82 Cr | 12 Mar 2020 | Open |
| 910637458 | Kotak Mahindra Bank Ltd(Bank) | ₹23.28 Cr | 27 Jan 2021 | Open |
| 253121807 | HDFC Bank Ltd(Bank) | ₹9.12 Cr | 04 Jul 2023 | Open |
| 256485779 | Kotak Mahindra Bank Ltd(Bank) | ₹22.74 Cr | 27 Jan 2019 | Satisfied |
| 647048764 | Kotak Mahindra Bank Ltd(Bank) | ₹15.47 Cr | 19 Sep 2023 | Open |
| 440011822 | Axis Bank Ltd(Bank) | ₹14.56 Cr | 19 Sep 2020 | Open |
Charge IDs, lenders & amounts for Venlon Enterprises Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2025-26 | — | ||||
| 2018-19 | — |
Detailed Financials
2 FYs| Line item | 2025-26 | 2018-19 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2025-26 | -10.0% | — | — | |
| Profit after Tax2025-26 | — | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2018-19 | -94.57% | — | — | -25.64% | — | |||
| 2025-26 | -42.57% | -68.08% | — | — | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 42,10,722 | 85.24% |
| Institutional Investors | 2 | 1,44,969 | 2.93% |
| Public & Others | 40 | 5,84,318 | 11.83% |
Promoter, institutional & public holding for Venlon Enterprises Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
228 peersTop 10 in Chemical substances used in the manufacture of anti-biotic, manufacturing
by healthView all ›Events & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.